These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6765528)

  • 1. Receptor binding studies and clinical effects of human insulin (recombinant DNA): studies in patients with newly diagnosed type i diabetes, type II diabetes, insulin resistance (type A and type B), insulin antibodies, insulin allergy, and "brittle" diabetes.
    Schlüter KJ; Kerp L
    Diabetes Care; 1982; 5 Suppl 2():152-60. PubMed ID: 6765528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of immune-mediated insulin resistance by human insulin (recombinant DNA).
    Maneschi F; Fineberg SE; Kohner EM
    Diabetes Care; 1982; 5 Suppl 2():175-9. PubMed ID: 6765532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistance.
    Schernthaner G
    Diabetes Care; 1982; 5 Suppl 2():114-8. PubMed ID: 6765520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of human monocomponent insulin with beef and pork monocomponent insulin in the treatment of a diabetic with insulin resistance].
    Wu W; Nolte M; Karam J
    Zhonghua Nei Ke Za Zhi; 1987 Nov; 26(11):644-5, 677. PubMed ID: 3327662
    [No Abstract]   [Full Text] [Related]  

  • 5. Human insulin (recombinant DNA) in the treatment of patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM).
    Lotz N; Bachmann W; Mehnert H
    Diabetes Care; 1982; 5 Suppl 2():149-51. PubMed ID: 6765527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of NPH human insulin (recombinant DNA) and pork insulin in diabetic subjects: preliminary report.
    Mirouze J; Monnier L; Richard JL; Gancel A; Soua KB
    Diabetes Care; 1982; 5 Suppl 2():60-2. PubMed ID: 6765543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study.
    Beyer J; Enzmann F; Lauerbach M; Althoff P; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Haas R
    Diabetes Care; 1982; 5 Suppl 2():140-8. PubMed ID: 6765526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic aspects of human proinsulin therapy.
    Fineberg SE; Rathbun MJ; Hufferd S; Fineberg NS; Spradlin CT; Galloway JA; Frank BH
    Diabetes; 1988 Mar; 37(3):276-80. PubMed ID: 3286327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-specific IgG and IgE antibody response in type I diabetic subjects exclusively treated with human insulin (recombinant DNA).
    Velcovsky HG; Federlin KF
    Diabetes Care; 1982; 5 Suppl 2():126-8. PubMed ID: 6765522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The U.S. "new patient" and "transfer" studies.
    Galloway JA; Peck FB; Fineberg SE; Spradlin CT; Marsden JH; Allemenos D; Ingulli-Fattic J
    Diabetes Care; 1982; 5 Suppl 2():135-9. PubMed ID: 6765525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossover study with human insulin (recombinant DNA) in type I diabetic subjects.
    Landgraf R; Kammerer S; Bock T; Smolka B; Ladik T; Enzmann F; Landgraf-Leurs MM
    Diabetes Care; 1982; 5 Suppl 2():39-42. PubMed ID: 6765538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patients.
    Clark AJ; Wiles PG; Leiper JM; Knight G; Adeniyl-Jones RO; Watkins PJ; Ward JD; MacCuish AC; Keen H; Jones RH
    Diabetes Care; 1982; 5 Suppl 2():129-34. PubMed ID: 6765523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance and allergy to recombinant human insulin.
    Ganz MA; Unterman T; Roberts M; Uy R; Sahgal S; Samter M; Grammer LC
    J Allergy Clin Immunol; 1990 Jul; 86(1):45-51. PubMed ID: 2196303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin allergy treated with human insulin (recombinant DNA).
    De Leeuw I; Delvigne C; Bekaert J
    Diabetes Care; 1982; 5 Suppl 2():168-70. PubMed ID: 6765530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.
    Zaccardi F; Webb DR; Yates T; Davies MJ
    Postgrad Med J; 2016 Feb; 92(1084):63-9. PubMed ID: 26621825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system.
    Klier M; Kerner W; Torres AA; Pfeiffer EF
    Diabetes Care; 1981; 4(2):193-5. PubMed ID: 7011725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship of HLA antigens to certain clinical forms of diabetes mellitus].
    Martinova F; Borisova AM; Minev M; Koev D; Genkova P
    Vutr Boles; 1989; 28(2):63-7. PubMed ID: 2669340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of allergy to heterologous monocomponent insulin with human semisynthetic insulin. Long-term study.
    Bruni B; Barolo P; Blatto A; Carlini M; Ansaldi SG; Grassi G
    Diabetes Care; 1988 Jan; 11(1):59-62. PubMed ID: 3276478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.